Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Curve Tirzepatide Review: Cost & Honest Verdict (2026)

An honest 2026 review of Curve tirzepatide — a shared 503A pharmacy and clinical network with other reviewed providers, and a site this review couldn't reach.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Shed (ShedRx)

Compounded tirzepatide from $239 with the widest set of formats here — injections, liquid drops, lozenges, and a real brand Zepbound pathway.

$299/mo

Check Shed (ShedRx) availability

This review attempted to independently verify Curve directly against trycurve.co and could not: the connection failed at the TLS handshake stage, before any content could be retrieved. Everything below is rather than a live reconfirmation.

Live verification was blocked

This review attempted to independently confirm Curve's current pricing and program details directly against trycurve.co. The connection failed at the TLS handshake stage — the site's server rejected the request before any content was served, blocking automated verification entirely. Every figure below was last verified on July 20, 2026. Visit trycurve.co directly to confirm current terms before committing.

§ Curve — What Live Verification Found

ItemStatus
Live verificationBlocked — TLS handshake failure
Tirzepatide price$225/mo month-to-month, $135/mo on 12-month prepay
Launch2026 — thin track record
This review's live pass failed at the TLS handshake; every fact here is from 2026-07-20.

What Curve is

Curve (Try Curve LLC) is a telehealth platform, offering compounded semaglutide and tirzepatide, prescribed by Beluga Health providers licensed in all 50 states and dispensed by VialsRx, a US 503A compounding pharmacy. Notably, both of these third-party partners also appear in other providers reviewed on this site — Beluga Health is Coby Health's clinical network, and VialsRx is one of Cora Health's named pharmacy partners — a common industry pattern where shared infrastructure serves multiple independent brands, not evidence of a duplicate.

What Curve costs

Every dose is priced the same within a tier, so cost doesn't rise as you titrate up. The cheapest headline rates — $99/month semaglutide, $135/month tirzepatide — require a 12-month prepay; true month-to-month pricing is $175 and $225 respectively.

A very new platform

Curve is a 2026 launch with a thin independent track record. At the time of prior research, the site still showed a Webflow template credit and a leftover reference to "Cora" in its Terms of Service — small signs of a very recently assembled site, worth knowing about. Both product pages also displayed an out-of-stock status at the time, so availability may be inconsistent.

The brand-vs-compounded question

Curve dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Curve's real strengths: flat per-tier pricing, a LegitScript-certified seal (#51079066), named partners (VialsRx pharmacy, Beluga Health providers), all-50-state availability with same-day review, and no membership fee. The trade-offs: it's a very new 2026 launch with a thin track record, showing signs of an incompletely finished site (a template credit, a leftover competitor reference in its Terms), the cheapest rates require a 12-month prepay, and both product pages showed out-of-stock status at last check. This review's own attempt to verify any of it live was also blocked at the connection level. As with any GLP-1 program, and especially a very new one this review couldn't verify live, confirm current availability and terms directly before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Curve's named pharmacy and provider network are genuine positives but this review couldn't reach the site at all this check, and the signs of an incompletely finished site plus out-of-stock product pages both warrant a direct check before committing. For an established provider using the same VialsRx pharmacy this review could independently verify live, compare Cora Health. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through Curve?

$225/month month-to-month, or $135/month on a 12-month prepay. This review could not independently reconfirm this live — trycurve.co's connection failed at the TLS handshake stage.

How long has Curve been operating?

It's a 2026 launch with a thin independent track record; the site showed signs of being newly assembled, including a leftover reference to a different provider in its Terms of Service.

Does Curve name its compounding pharmacy?

Yes — VialsRx, a US 503A compounding pharmacy also named by Cora Health, another provider reviewed on this site.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.